Related Experiment Video
Updated: Feb 7, 2026

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
Loris Riccardo Lopetuso1, Giammarco Mocci2, Manuela Marzo3
1Internal Medicine and Gastroenterology Department, Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore, 00168 Roma, Italy. lopetusoloris@libero.it.
Abstract:
Anti-tumor necrosis factor (TNF)-α agents represent an effective treatment for chronic inflammatory diseases. However, some concerns about their potentially undesirable effects on liver function have been reported. On the other hand, evidence of their therapeutic effects on certain liver diseases is accumulating. Many data showed the safety of anti-TNF-α in patients with chronic hepatitis B and C and in liver transplanted patients even if a strict follow-up and prophylaxis are recommended in well-defined subgroups. On the other side, anti-TNF-α-induced liver injury is not a rare event. However, it is often reversible after anti-TNF-α withdrawal. Anti-TNF-α agents have been tested in advanced stages of severe alcoholic hepatitis and non-alcoholic fatty liver disease. Limited data on the efficacy of anti-TNF-α in patients with autoimmune hepatitis and primary biliary cholangitis are also available. In this review, we explored the hepatic safety concerns in patients receiving anti-TNF-α agents with and without pre-existent hepatic diseases. In addition, the available evidence on their potential benefits in the treatment of specific hepatic diseases is discussed.
Insights
Anti-tumor necrosis factor (TNF)-α agents are effective for inflammatory diseases but can affect liver function. This review examines their hepatic safety and potential therapeutic benefits in various liver conditions.
Area of Science:
- Hepatology
- Immunology
- Pharmacology
Background:
- Anti-tumor necrosis factor (TNF)-α agents are widely used for chronic inflammatory diseases.
- Concerns exist regarding their impact on liver function, yet evidence suggests therapeutic potential in certain liver diseases.
Purpose of the Study:
- To review the hepatic safety of anti-TNF-α agents in patients with and without pre-existing liver conditions.
- To discuss the potential benefits of anti-TNF-α agents in treating specific liver diseases.
Main Methods:
- Literature review of studies on anti-TNF-α agents and liver diseases.
- Analysis of safety data and efficacy evidence from clinical trials and observational studies.
Main Results:
- Anti-TNF-α agents are generally safe in patients with chronic hepatitis B/C and liver transplant recipients, requiring monitoring.
- Anti-TNF-α-induced liver injury can occur but is often reversible upon drug withdrawal.
- Limited data exist on efficacy in autoimmune hepatitis and primary biliary cholangitis, with ongoing research in alcoholic and non-alcoholic fatty liver disease.
Conclusions:
- Anti-TNF-α agents present a complex profile regarding liver health, with both risks and potential benefits.
- Careful patient selection, monitoring, and prophylaxis are crucial when using anti-TNF-α agents in patients with liver conditions.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Factors Affecting α-Alkylation of Ketones: Choice of Base
The reaction involving bases like EtO− whose conjugate acid EtOH (pKa = 15.9) is stronger than the ketone (pKa = 19.2) results in an equilibrium mixture with higher ketone concentration. As a consequence,...
Benefits of Self-Esteem
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Framing Effects

